The Journal of Immunology, Vol 149, Issue 5 1744-1750, Copyright © 1992 by American Association of Immunologists

ARTICLES

Role of complement in endotoxin/platelet-activating factor-induced lung injury

R Rabinovici, CG Yeh, LM Hillegass, DE Griswold, MJ DiMartino, J Vernick, KL Fong and G Feuerstein
Department of Surgery, Jefferson Medical College, Philadelphia, PA 19107-5083.

C receptor-1 is a protein involved in the regulation of C3 and C5- convertases. Recombinant human soluble C receptor-1 has recently been produced and shown to reduce infarct size in a rat model of myocardial ischemia/reperfusion injury. The present study aimed to investigate whether recombinant human soluble C receptor-1 exerts any protective effect on pulmonary injury produced in a rodent model of adult respiratory distress syndrome. In this model, Escherichia coli endotoxin (LPS, 0.1 microgram/kg) combined with platelet-activating factor (1 pmol/kg/min over 60 min, n = 10) caused microvascular lung injury characterized by elevation of myeloperoxidase activity, deposition of C3 and C5b-9 on the endothelium of pulmonary vessels, and pulmonary edema. Furthermore, bronchoalveolar lavage revealed increased neutrophil count and elevated protein concentration. These pulmonary responses were associated with elevated serum TNF-alpha. Pretreatment (10 min, i.v.) with recombinant human soluble C receptor-1 at 10 mg/kg (n = 13), but not at 1 mg/kg, prevented the LPS/platelet-activating factor-induced pulmonary edema (p less than 0.01) and changes in the bronchoalveolar lavage fluid cell count (p less than 0.01) and protein concentration (p less than 0.05), and attenuated the deposition of C3 and C5b-9 to lung vessels. There was no effect on lung myeloperoxidase activity and serum TNF-alpha. Also, C depletion by cobra venom factor (500 U/kg, i.v.) eliminated the pulmonary edema and elevated leukocyte count in bronchoalveolar lavage fluid, but had no effect on lung myeloperoxidase activity and serum TNF-alpha. These data suggest that C factors may play an important role in the pathophysiology of adult respiratory distress syndrome.

This article has been cited by other articles:

				D. Rittirsch, M. A. Flierl, D. E. Day, B. A. Nadeau, S. R. McGuire, L. M. Hoesel, K. Ipaktchi, F. S. Zetoune, J. V. Sarma, L. Leng, et al. Acute Lung Injury Induced by Lipopolysaccharide Is Independent of Complement Activation J. Immunol., June 1, 2008; 180(11): 7664 - 7672. [Abstract] [Full Text] [PDF]

				C. Caliezi, W. A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele, and C. E. Hack C1-Esterase Inhibitor: An Anti-Inflammatory Agent and Its Potential Use in the Treatment of Diseases Other Than Hereditary Angioedema Pharmacol. Rev., March 1, 2000; 52(1): 91 - 112. [Abstract] [Full Text] [PDF]

				R. A. Schmid, A. Zollinger, T. Singer, S. Hillinger, J. R. Leon-Wyss, O. M. Schob, K. Hogasen, G. Zund, G. A. Patterson, and W. Weder Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 90 - 94. [Abstract] [Full Text]

				S. C. Makrides Therapeutic Inhibition of the Complement System Pharmacol. Rev., March 1, 1998; 50(1): 59 - 88. [Abstract] [Full Text] [PDF]

				R. Rabinovici, L.F. Neville, and G. Feuerstein Current understanding of sepsis: criticism and a proposal Innate Immunity, June 1, 1995; 2(3): 163 - 168. [Abstract] [PDF]